TRAXAM PAIN RELIEF

5cm) of gel) into the affected area(s) 2 to 4 times a day. Do not use for longer than 7 days. The total daily dose should not exceed 25g per day regardless of the number of affected areas.

Elderly:

No special dosage recommendations are made for elderly patients. Paediatric Population Not recommended for use in children under 12 years of age. Method of administration Topical application to affected area. Hands should be washed following application of Traxam Gel unless they are the treatment site.

The following adverse reactions are classified by system organ class and ranked under heading of frequency using the following convention: common (≥1/100, <1/10), rare (≥1/10,000, ≤1/1000), Not known (cannot be estimated from the available data).

The overall incidence of side effects reported with Traxam Gel is low (less than 2%). MedDRA System Organ Class Frequency Undesirable Effects Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.

It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

Use of Traxam Gel should be limited to intact and non-diseased skin. Contact with mucous membranes and the eyes should be avoided. Discontinue if rash develops. Felbinac gel should not be applied with occlusive dressings at the same site as other topical preparations.

Topical application of large amounts may result in systemic effects, such as hypersensitivity, asthma and renal disease. To avoid the possibility of photosensitivity, patients are advised against excessive exposure to sunlight of treated areas.

Safe use of Felbinac in early childhood has not been established. Instruct patients not to smoke or go near naked flames - risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard.

Washing clothing and bedding may reduce product build-up but not totally remove it. This medicine contains 300 mg of alcohol (ethanol) in each 1 g which is equivalent to 300 mg/g (30%w/w). It may cause burning sensation on damaged skin.

1. Patients in whom attacks of asthma, urticaria or acute rhinitis are precipitated by aspirin or other non-steroidal anti-inflammatory drugs. Children under 12 years of age.